Clinical Trials Directory

Trials / Unknown

UnknownNCT05600374

Brain-Oscillation-Synchronized Stimulation to Enhance Motor Recovery in Early Subacute Stroke

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
144 (estimated)
Sponsor
University Hospital Tuebingen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

We will investigate the therapeutic efficacy of EEG-synchronized noninvasive repetitive transcranial magnetic stimulation (rTMS) in the early subacute phase after ischemic stroke to improve upper limb motor rehabilitation. We hypothesize that synchronization of rTMS with the phase of the ongoing sensorimotor oscillation indicating high corticospinal excitability leads to significantly stronger improvement of paretic upper limb motor function than the same rTMS protocol non-synchronized to the ongoing sensorimotor oscillation or sham stimulation.

Detailed description

High-frequency rTMS will be applied to the ipsilesional motor cortex in 400 bursts of 100 Hz triplets with a mean inter-burst interval of 3 s (20 min treatment duration, 1,200 pulses per day) for 5 consecutive workdays (6,000 pulses total) at a stimulus intensity of 80% of resting motor threshold, in one of three conditions/arms, followed by 40 min task-specific hand/arm-physiotherapy.

Conditions

Interventions

TypeNameDescription
DEVICEBossdeviceThe bossdevice is a real-time digital signal processor consisting of hardware and software algorithms. It is designed to read-in a real-time raw data stream from a bio-signal amplifier (electroencephalography, EEG), to continuously analyze this data and to detect patterns based on oscillations in different frequencies. When such a specific bio-signal pattern is detected, the device indicates this through a standard output port. This enables a connected device to know with millisecond accuracy when a specific biosignal pattern occurs.

Timeline

Start date
2023-02-06
Primary completion
2025-05-31
Completion
2026-02-28
First posted
2022-10-31
Last updated
2023-11-22

Locations

7 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT05600374. Inclusion in this directory is not an endorsement.